Total revenues increased by 7% to $3.29 billion in 2025, up from $3.09 billion in 2024. Net income surged by 60% to $751.2 million in 2025, compared to $470.5 million in 2024, largely due to the absence of a significant loss from discontinued operations present in 2024. Income from continuing operations before income taxes grew by 4% to $974.6 million in 2025. Diluted earnings per share from continuing operations rose by 9.1% to $22.91 in 2025, from $20.99 in 2024. The Board of Directors declared a quarterly dividend of $1.20 per share in Q1 2026, and total dividends declared per share for 2025 were $4.16, up from $3.30 in 2024. A new $475.0 million share repurchase program was authorized from November 19, 2025, through December 31, 2026, following the completion of a $450.0 million program in 2025. The Investment and Savings Products segment saw an 18% increase in total revenues and income before income taxes, driven by strong product sales and higher average client asset values of $119.6 billion. The Term Life Insurance segment reported a 3% increase in total revenues and income before income taxes, despite a 10.4% decrease in new policies issued and a 19.6% decline in new recruits. The number of life insurance-licensed independent sales representatives remained relatively flat at 151,524 at year-end 2025. Net cash provided by operating activities increased to $901.2 million in 2025, up from $862.1 million in 2024. The company disposed of its Senior Health business as of September 30, 2024, which resulted in a significant loss in 2024 but improved continuing operations in 2025. The average book yield of the fixed-maturity investment portfolio increased to 4.30% as of December 31, 2025, reflecting higher reinvestment rates.